Wednesday, August 27, 2014
Add My Products
Showing Results 1 - 0 of 0
MU Researchers Discover Protein's Ability To Inhibit HIV Release
TIM-family proteins have the ability to block the release of HIV and other viruses.
Experimental Chikungunya Vaccine Induces Robust Antibody Response
Vaccine developed by NIH scientists performs well in early clinical trial.
The Future of Targeted Therapy in Rheumatology: Biologics or Small Molecules?
While biologics can modulate extracellular protein-protein interactions, intracellular processes can be more effectively targeted by small molecules.
Injected Vaccine Could Help Eradicate Polio
Re-introducing a type of polio vaccine that fell out of favour in the 1960s could hasten eradication of the disease.
Can Regenerative Medicine be the Cure for Cancer and Other Deadly Diseases?
Change in regulatory frameworks and standards are essential to expedite approval and release of innovative products.
A Key Step Toward a Safer Strep Vaccine
Gene discovery identifies molecular pathway to potential preventive treatment.
Separation of mAbs Molecular Variants by Analytical HIC-HPLC
HIC-HPLC is a less widely used analytical technique compared with standard methods for separating variants based on size, charge or electrophoretic mobility.
HIV Vaccine Awareness Day
Early stage vaccine clinical trials are expected to begin in South Africa in early 2015.
Decline in Whooping Cough Cases Continues
PHE publish whooping cough figures which are on a decline across England.
Scripps Researchers Find New Point of Attack on HIV for Vaccine Development
The newly identified site can be attacked by human antibodies in a way that neutralizes the infectivity of a wide variety of HIV strains.
Advertise On This Site
Terms & Conditions
©2014 Technology Networks
, all rights reserved.